HRT Financial’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-58,618
Closed -$389K – 3439
2023
Q1
$389K Buy
58,618
+10,345
+21% +$87.4K ﹤0.01% 1560
2022
Q4
$502K Sell
48,273
-127
-0.3% -$1.3K 0.01% 1420
2022
Q3
$493K Sell
48,400
-600
-1% -$6.12K 0.01% 1596
2022
Q2
$497K Hold
49,000
– – 0.01% 1579
2022
Q1
$494K Hold
49,000
– – ﹤0.01% 1791
2021
Q4
$489K Buy
+49,000
New +$489K ﹤0.01% 1900

Other funds holding OCEA

HRT Financial's OCEA Position: Q2 2023 in Review

HRT Financial sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2023, closing a stake of 58,618 shares — an estimated $389K sold.

HRT Financial first reported a position in OCEA in Q4 2021 and held it in 6 quarters. The position peaked at $502K in Q4 2022. 35 funds tracked by Wall St. Rank hold OCEA as of Q2 2023.

  • HRT Financial reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 58,618 Ocean Biomedical, Inc. Common Stock shares in Q2 2023, an estimated $389K.
  • HRT Financial first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • HRT Financial's Ocean Biomedical, Inc. Common Stock position peaked at $502K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.